January 2020 - Page 8 of 9

Stock Analysis: Else Nutrition Holdings Inc (TSX.V:BABY) (OTCQB:BABYF)

Five Key Investment Highlights about Else Nutrition Holdings Inc. (TSX.V:BABY) (OTCQB:BABYF) Else Nutrition Holdings Inc. (TSX.V:BABY) (OTCQB:BABYF) has developed a breakthrough, science-backed product that is the first 100% plant-based, non-dairy, non-soy infant formula. Else Nutrition ... [Read]

Penny Stocks to Watch: aTyr Pharma and Pulmatrix

Jan 7 Caileam Raleigh

We’re officially a full week into the new decade, and investors will surely be eager to start it off on the right foot. Well, fear not, because we’re here with Tuesday’s pick of penny stocks ... [Read]

XERS Stock Jumps 12% Following Positive RTU Glucagon Data

Jan 7 Ankit Singhania

When a pharmaceutical company announces positive results from any stage of a clinical study, then it almost always has a positive effect on the company’s stock. That is what happened with XERS stock in the ... [Read]

Waitr Stock Pops After Announcing New CEO Appointment

Jan 6 Caileam Raleigh

Waitr stock is in the green today after the struggling food delivery service named Carl Grimstad as its new CEO following the sudden resignation of Adam Price after only four months. Waitr Stock Boosted By ... [Read]

PLUG Stock Jumps 14% After Announcing $172 Million Order

Jan 6 Ankit Singhania

PLUG stock is gaining momentum this morning after Plug Power Inc (NASDAQ:PLUG) received an order at the close of 2019 from a Fortune 100 customer for hydrogen fuel cell deployments. Investors Cheer the News One ... [Read]

Natera Announces Achievement of $55 Million In Pharma Contracts and Issuance of New Oncology Patents

Jan 6

This Post Was Syndicated Under License Via QuoteMedia Exceeds 2019 goal of $40-$50 million in cumulative contracts with pharmaceutical companies and extends leadership in ctDNA MRD SAN CARLOS, Calif., Jan. 6, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: ... [Read]